Mild parenchymal lung disease is still lung disease

Robin Condliffe, David G. Kiely, Robert A. Lewis

Source: Eur Respir J, 56 (5) 2003727; 10.1183/13993003.03727-2020

Journal Issue: November

Disease area: Interstitial lung diseases, Pulmonary vascular diseases

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Robin Condliffe, David G. Kiely, Robert A. Lewis. Mild parenchymal lung disease is still lung disease. Eur Respir J, 56 (5) 2003727; 10.1183/13993003.03727-2020

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Siphonage lung disease Source: Virtual Congress 2020 – Respiratory critical care Year: 2020
Nitrofurantoin-induced interstitial lung disease Source: Annual Congress 2012 - Viral infections and rare respiratory infections Year: 2012
Diffuse parenchymal lung disease Source: Eur Respir Rev, 26 (144) 170004; 10.1183/16000617.0004-2017 Year: 2017
Diffuse parenchymal lung disease Source: International Congress 2016 – Clinical year in review Year: 2016
Senotherapies for chronic lung disease Source: ERS Lung Science Conference 2020 Year: 2020
Update on diffuse parenchymal lung disease Source: Eur Respir Rev 2009; 19: 97-108 Year: 2010
Alveoscopy in diffuse interstitial lung disease Source: Eur Respir J 2007; 30: Suppl. 51, 244s Year: 2007
Rituximab in severe, progressive interstitial lung disease Source: International Congress 2016 – Connective tissue disorders Year: 2016
Addition of respiratory hospitalizations 24weeks prior to the ILD-GAP model to predict mortality in chronic interstitial lung disease Source: International Congress 2016 – Clinical aspects of ILD Year: 2016
Diffuse parenchymal lung diseases Source: ERS Skills Course 2016 Year: 2016
Diffuse parenchymal lung diseases Source: ERS Skills Course 2017 - Summer school of adult respiratory medicine Year: 2017
Diffuse parenchymal lung diseases Source: ERS Course 2019 - Summer school of adult respiratory medicine Year: 2019
Diffuse parenchymal lung diseases Source: ERS Course 2018 - Summer school of adult respiratory medicine Year: 2018
Using the ILD-GAP model to predict mortality in chronic interstitial lung disease Source: International Congress 2015 – IIPs: orphan Year: 2015
Rituximab in severe, treatment-refractory interstitial lung disease Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease Year: 2013
A multicentre evaluation of inter-multidisciplinary team agreement for diagnosis in diffuse lung disease Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases Year: 2016